Mobilization of peripheral blood stem cells

Transfusion and Apheresis Science

Volumn 37, Issue 2, 2007, Pages 179-185

  Arslan, Önder ^a   Moog, Rainer ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Adverse events; Large volume leukapheresis; Mobilization; Peripheral blood stem cells

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; CARMUSTINE; CHEMOKINE RECEPTOR CXCR4; CTCE 0021; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 12; INTERLEUKIN 3; INTERLEUKIN 7; MELPHALAN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PARACETAMOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR; UNCLASSIFIED DRUG;

APHERESIS; ARTICLE; BLOOD VOLUME; BONE MARROW TRANSPLANTATION; BONE PAIN; CD34 SELECTION; CELL FUNCTION; DIZZINESS; DRUG HALF LIFE; FLU LIKE SYNDROME; GRAFT FAILURE; HEADACHE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; MYALGIA; NAUSEA; PERIPHERAL BLOOD STEM CELL; SIDE EFFECT; SINGLE DRUG DOSE; SPLENOMEGALY; STEM CELL MOBILIZATION;

ANIMALS; ANTIGENS, CD34; ERYTHROPOIETIN; FILGRASTIM; HEMATOPOIETIC STEM CELL MOBILIZATION; HETEROCYCLIC COMPOUNDS; HUMANS; LEUKAPHERESIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

EID: 36549026786     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.08.002     Document Type: Article

References (70)

1. Thomas E.D., Lochte Jr. H.L., Cannon J.H., Sahler O.D., and Ferrebee J.W. Supralethal whole body irradiation and isologous marrow in man. J Clin Invest 38 (1959) 1709-1716
2. Armitage J.O. Bone marrow transplantation. New Engl J Med 330 (1994) 827-838
3. Goodman G.E., and Hodgson G.S. Evidence for stem cells in the peripheral blood of mice. Blood 19 (1962) 702-714
4. McCredie K., Hersh E., and Fredereich E. Cells capable of colony information in the peripheral blood of man. Science 171 (1971) 293-294
5. Weiner R.S., Richman C.M., and Yankee R.A. Semicontinuous flow centrifugation for the pheresis of immunocompetent cells and stem cells. Blood 49 (1977) 391-397
6. Gillespie T.W., and Hillyer C.D. Peripheral blood progenitor cells for marrow reconstitution: mobilization and collection strategies. Transfusion 36 (1996) 611-621
7. Hillyer C.D., Tiegerman K.O., and Berkman W.M. Increase in circulating colony-forming units granulocyte-macrophage during large-volume leukapheresis: Evaluation of a new cell separator. Transfusion 31 (1991) 327-332
8. Goldman J.M., Catovsky D., Hows J., Spiets A.S.D., and Galton D.A.G. Cryopreserved peripheral blood cells functioning as autografts in patients with chronic granulocytic leukemia in transformation. Br Med J 1 (1979) 1310-1313
9. Körbling M., Borke P., Braine H., Elfenbein 0., Santos G.W., and Kaizer H. Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemina. Exp Hematol 9 (1981) 684-690
10. Körbling M., Dörken B., Ho A.D., Pezzutto A., Hunstein W., and Fliedner T.M. Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 67 (1986) 529-532
11. Juttner C.A., To L.B., Haylock D.N., Branford A., and Kimber R.G. Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete reconstitution after high dose melphalan or supralethal radiotherapy. Br J Haematol 61 (1985) 739-745
12. Kessinger A., Armitage J.O., and Landmark J.D. Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. Exp Hematol 14 (1986) 192-196
13. Reiffer J., Bernard I., and David B. Successful autologous transplantation with peripheral blood hematopoietic cells in patients with acute leukemia. Exp Hematol 14 (1986) 312-315
14. Kessinger A., Smith D.M., Strandford S.W., et al. Allogeneic transplantation of blood-derived, T-cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transpl 4 (1989) 643-646
15. Dreger P., Suttorp M., Haferlach T., Loffler H., and Schmitz N. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 81 (1993) 1404-1409
16. Bensinger W.I., Weaver C.H., Appelbaum F.R., et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulated factor. Blood 85 (1995) 1655-1658
17. Körbling M., Przepiorka D., Yo H., et al. Allogeneic blood cell transplantation for leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 85 (1995) 1659-1665
18. Schmitz N., Dreger P., and Suttorp M. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85 (1995) 1666-1672
19. Kessinger A., Armitage J.O., Landmark J.D., and Weisenberger D. Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. Exp Hematol 14 (1986) 192-196
20. Dreger P., Klöss M., Petersen B., Haferlach T., Löffler H., Loeffler M., et al. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not bone marrow grafts. Blood 86 (1995) 3970-3978
21. Lasky L.C., Hurd D.D., Smith J.A., and Haake R. Peripheral blood stem cell collection and use in Hodgkin's disease. Comparison with marrow in autologous transplantation. Transfusion 29 (1989) 323-327
22. Ottinger D., Beelen D.W., Scheulen B., Schaefer U.W., and Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88 (1996) 2775-2779
23. Russel N.H., and Pacey S. Economic evaluation of peripheral blood stem transplantation for lymphorna. Lancet 340 (1992) 1280-1282
24. Bensinger W.I., Martin P.J., Storer B., et al. Transplantation of bone marrow as with peripheral blood cells from HLA-identical realtives in patients with hematologic malignancies. N Engl J Med 344 (2001) 175-181
25. Sheridan W.P., Begley C.G., Juttner C.A., et al. Effect of peripheral blood progenitor cell mobilised by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 339 (1992) 640-643
26. Henon P. New developments in peripheral blood stem cell transplants. Leukemia 6 Suppl. 4 (1992) 106-109
27. Beyer J., Schwella N., Zingsem J., et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 13 (1995) 1328-1335
28. Richman C.M., Weiner R.S., and Yankee R.S. Increase in circulating stem cells following chemotherapy in man. Blood 47 (1976) 1031-1039
29. Gianni A.M., Siena S., Bregni M., et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating hematopoietic stem cells for autotransplanatation. Lancet 2 (1989) 580-584
30. Weaver C.H., Schwartzberg L.S., Birch R., et al. Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patients. Transfusion 37 (1997) 896-903
31. Haas R., Möhle R., Frühauf S., et al. Patient characteristics associated with successful mobilizing and autografting of peripheral progenitor cells in malignant lymphoma. Blood 83 (1994) 3787-3794
32. Kasparu H., Krieger O., Girschikofsky M., Kolb A., Bettelheim P., and Lutz D. Factors influencing the timing of peripheral blood stem cell collection (PBSC). Transfus Apheresis Sci 17 (1996) 595-600
33. Anderlini F., Przepiorka D., Seong C., et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion 37 (1997) 507-512
34. de la Rubia J., Arbona C., de Arriba F., et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 42 (2002) 4-9
35. Höglund M., Smedmyr B., Bengtsson M., et al. Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy donors - comparative study. Eur J Haematol 59 (1997) 177-183
36. Watts M.J., Addison I., Long S.G., et al. Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylated G-CSF in healthy volunteers. Br J Haematol 98 (1997) 474-479
37. Kröger N., Renges H., Krüger W., et al. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. Br J Haematol 111 (2000) 761-765
38. Kröger N., Zeller W., Hasan H.T., et al. Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering doses (2 × 5 μg/kg) compared to a single dose (1 × 10 μg/kg). Bone Marrow Transplant 23 (1999) 125-129
39. Malachowski M.E., Comenzo R.L., Hillyer C.D., Tiegerman K.O., and Berkman E.M. Large-volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion 32 (1992) 732-735
40. Smolowicz A.G., Villman K., and Tidefelt U. Large-volume apheresis for the harvest of peripheral blood progenitor cells for autologous transplantation. Transfusion 37 (1997) 188-192
41. Humpe A., Riggert J., Munzel U., et al. A prospective, randomized, sequential, crossover trial of large-volume versus normal-volume leukapheresis procedures: effect on progenitor cells and engraftment. Transfusion 39 (1999) 1120-1127
42. Menichella G., Lai M., Serafini R., et al. Large volume leukapheresis for collecting hemopoietic progenitors: role of CD34+ precount in predicting successful collection. Int J Art Organs 22 (1999) 334-341
43. Torrabadella M., Olive T., Ortega J.J., and Massuet L. Enhanced HPC recruitment in children using LVL and a new automated apheresis system. Transfusion 40 (2000) 404-410
44. Bojko P., Scharifi M., Stössel K., and Seeber S. Comparison of processing four and five times the patients' blood volume during peripheral blood stem cell collection and analysis of CD34-38- and CD34CD49d+ subsets during apheresis. J Cancer Res Oncol 128 (2002) 19-28
45. Accorsi P., Dell'Isola M., Bonfini T., et al. Large volume leukapheresis with AMICUS cell separator in peripheral blood stem cell autologous transplant. Transfus Apheresis Sci 24 (2001) 79-83
46. Murea S., Goldschmidt H., Hahn U., Pförsich M., Moos M., and Haas R. Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses. J Clin Apheresis 11 (1996) 185-194
47. Cassens U., Ostkamp-Ostermann P., van der Werf N., Garritsen H., Ostermann H., and Sibrowski W. Volume-dependant collection of peripheral blood progenitor cells during large-volume leukapheresis for patients with solid tumours and haematological malignancies. Transfusion Med 9 (1999) 311-320
48. Lin J.S., Burgstaler E.A., Pineda A.A., and Gertz M.A. Effects of whole blood flow rate on monononuclear cell yields during peripheral blood stem collection using Fenwal CS 3000 Plus. J Clin Apheresis 10 (1995) 7-11
49. Bolan C.D., Carter C.S., Wesley R.A., et al. Prospective evaluation of cell kinetics, yields and donor experiences during a single large-volume apheresis versus two smaller volume consecutive day collections of allogeneic peripheral blood stem cells. Br J Hematol 120 (2003) 801-807
50. Humpe A., Riggert J., Munzel U., and Köhler M. A prospective, randomized, sequential crossover trial of large-volume versus normal-volume leukapheresis procedures: effects on serum electrolytes, platelet counts, and other coagulation measures. Transfusion 40 (2000) 368-374
51. Alegre A., Diaz M.A., Madero L., et al. Large-volume leukapheresis for peripheral blood stem cell collection in children: a simplified single-apheresis approach. Bone Marrow Transpl 17 (1996) 923-927
52. Gorlin J.B., Vamvakas E.C., Cooke E., Galacki D., Geha R., Humphreys D., et al. Large-volume leukapheresis in pediatric patients: processing more blood diminishes the apparent magnitude of intra-apheresis recruitment. Transfusion 36 (1996) 879-885
53. Zingsem J., Zeiler T., Zimmermann R., et al. Selective enrichment of hematopoietic progenitor cells from peripheral blood. Transfus Sci 14 (1993) 75-77
54. Knudsen L.M., Nikolaisen K., Gaarsdal E., and Johnsen H.E. Kinetic studies during peripheral blood stem cell collection show CD34+ cell recruitment intra-apheresis. J Clin Apheresis 16 (2001) 114-119
55. Dreger P., Marquardt P., Haferlach T., et al. Effective mobilisation of peripheral blood progenitor cells with Dexa-BEAM and G-CSF: timing of harvesting and composition of leukapheresis product. Br J Cancer 68 (1993) 950-957
56. Cassens U., Barth I.M., Baumann C., et al. Factors affecting the efficacy of peripheral blood progenitor cell collection by large-volume leukapheresis with standardized processing volumes. Transfusion 44 (2004) 1593-1602
57. Abrahamsen J.F., Stamnesfet S., Liseth K., Hervig T., and Bruserud O. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells. Transfusion 45 (2005) 248-253
58. Gasova Z., Marinov I., Vodvarkova S., Böhmava M., and Bhuyian-Ludvikova Z. PBSC collection techniques: standard versus large volume leukapheresis (LVL) in donors and in patients. Transfusion Apheresis Sci 32 (2005) 167-176
59. Anderlini P., Przepiorka D., Seong D., et al. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors and analysis of charges for the procedures. Transfusion 36 (1996) 590-595
60. Stroncek D.F., Clay M.E., Petzold M.L., et al. Treatment of normal individuals with granulocyte-colony stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 36 (1996) 601-610
61. Anderlini P., Körbling M., Dale D., et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood 90 (1997) 903-908
62. Platzbecker U., Prange-Krex G., Bornhäuser M., et al. Spleen enlargement in healthy donors during G-CSF mobilization of PBSCs. Transfusion 41 (2001) 184-189
63. Stroncek D., Shawker T., Follmann D., and Leitman S.F. G-CSF-induced spleen size changes in peripheral blood progenitor cell donors. Transfusion 43 (2003) 609-613
64. Becker P.S., Wagle M., Matous S., et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): Occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 3 (1997) 45-49
65. Falzetti F., Aversa F., Minelli O., and Tabilio A. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet 353 (1999) 555
66. Broxmeyer H.E., Orschell C.M., Clapp D.W., Hangoc G., Cooper S., Plett P.A., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201 8 (2005) 1307-1318
67. Flomenberg N., Devine S.M., Dipersio J.F., Liesveld J.L., McCarty J.M., Rowley S.D., et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 106 (2005) 1867-1874
68. Burroughs L., Mielcarek M., Little M.T., Bridger G., Macfarland R., Fricker S., et al. Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model. Blood 106 (2005) 4002-4008
69. Molineux G. The design and development of pegfilgrastim (PEG-rmetHuG-CSF, Neulasta). Curr Pharm Des 10 (2004) 1235-1244
70. Pelus L.M., Bian H., Fukuda S., Wong D., Merzouk A., and Salari H. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor. Exp Hematol 33 (2005) 295-307